Research Article
Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking
Table 1
Pharmacological and molecular properties of triptolide.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: caco-2: caco-2 permeability; OB: oral bioavailability; Dl: drug likeness; BBB: blood–brain barrier. |